Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
420.07
-1.95 (-0.46%)
At close: Oct 30, 2026, 4:00 PM EDT
423.81
+3.74 (0.89%)
After-hours: Oct 30, 2026, 7:32 PM EDT
Elevance Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 164,697 | 164,639 | 144,166 | 142,854 | 133,229 | 117,373 |
Total Interest & Dividend Income | 2,999 | 2,194 | 2,051 | 1,825 | 1,485 | 1,378 |
Other Revenue | 34,136 | 32,293 | 30,593 | 26,661 | 21,885 | 19,892 |
| 201,832 | 199,126 | 176,810 | 171,340 | 156,599 | 138,643 | |
Revenue Growth | 3.60% | 12.62% | 3.19% | 9.41% | 12.95% | 13.76% |
Policy Benefits | 148,483 | 148,223 | 127,567 | 124,330 | 116,642 | 102,571 |
Amortization of Goodwill & Intangibles | 492 | 628 | 580 | 885 | 767 | 441 |
Selling, General & Administrative | 44,830 | 41,978 | 38,800 | 36,236 | 30,728 | 26,604 |
Total Operating Expenses | 193,805 | 190,829 | 166,947 | 161,451 | 148,137 | 129,616 |
Operating Income | 8,027 | 8,297 | 9,863 | 9,889 | 8,462 | 9,027 |
Interest Expense | -1,446 | -1,403 | -1,185 | -1,030 | -855 | -802 |
EBT Excluding Unusual Items | 6,581 | 6,894 | 8,678 | 8,859 | 7,607 | 8,225 |
Merger & Restructuring Charges | -202 | -55 | -268 | -752 | -7 | -202 |
Gain (Loss) on Sale of Assets | - | - | 201 | - | - | - |
Asset Writedown | -129 | -129 | -41 | -392 | - | -7 |
Legal Settlements | - | - | -666 | - | - | - |
Other Unusual Items | - | - | - | - | - | -21 |
Pretax Income | 6,250 | 6,710 | 7,904 | 7,715 | 7,600 | 7,995 |
Income Tax Expense | 1,147 | 1,049 | 1,933 | 1,724 | 1,712 | 1,846 |
Earnings From Continuing Ops. | 5,103 | 5,661 | 5,971 | 5,991 | 5,888 | 6,149 |
Minority Interest in Earnings | 36 | 1 | 9 | -4 | 6 | 9 |
Net Income | 5,139 | 5,662 | 5,980 | 5,987 | 5,894 | 6,158 |
Net Income to Common | 5,139 | 5,662 | 5,980 | 5,987 | 5,894 | 6,158 |
Net Income Growth | -7.12% | -5.32% | -0.12% | 1.58% | -4.29% | 34.69% |
Shares Outstanding (Basic) | 219 | 224 | 232 | 236 | 240 | 244 |
Shares Outstanding (Diluted) | 219 | 225 | 233 | 237 | 243 | 247 |
Shares Change | -3.33% | -3.56% | -1.90% | -2.22% | -1.62% | -2.95% |
EPS (Basic) | 23.51 | 25.28 | 25.81 | 25.38 | 24.56 | 25.26 |
EPS (Diluted) | 23.44 | 25.21 | 25.68 | 25.22 | 24.28 | 24.95 |
EPS Growth | -3.90% | -1.83% | 1.82% | 3.87% | -2.69% | 38.77% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 6,514 | 3,174 | 4,552 | 6,765 | 7,247 | 7,277 |
Free Cash Flow Per Share | 29.70 | 14.13 | 19.55 | 28.50 | 29.85 | 29.48 |
Dividend Per Share | 6.870 | 6.840 | 6.520 | 5.920 | 5.120 | 4.520 |
Dividend Growth | 1.63% | 4.91% | 10.13% | 15.63% | 13.27% | 18.95% |
Operating Margin | 3.98% | 4.17% | 5.58% | 5.77% | 5.40% | 6.51% |
Profit Margin | 2.55% | 2.84% | 3.38% | 3.49% | 3.76% | 4.44% |
Free Cash Flow Margin | 3.23% | 1.59% | 2.57% | 3.95% | 4.63% | 5.25% |
EBITDA | 8,713 | 9,040 | 10,522 | 10,949 | 9,538 | 9,844 |
EBITDA Margin | 4.32% | 4.54% | 5.95% | 6.39% | 6.09% | 7.10% |
D&A For EBITDA | 686 | 743 | 659 | 1,060 | 1,076 | 817 |
EBIT | 8,027 | 8,297 | 9,863 | 9,889 | 8,462 | 9,027 |
EBIT Margin | 3.98% | 4.17% | 5.58% | 5.77% | 5.40% | 6.51% |
Effective Tax Rate | 18.35% | 15.63% | 24.46% | 22.35% | 22.53% | 23.09% |
Revenue as Reported | 201,831 | 199,125 | 177,011 | 171,340 | 156,595 | 138,639 |